1. Home
  2. CYTK vs SM Comparison

CYTK vs SM Comparison

Compare CYTK & SM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

SELL

Current Price

$62.30

Market Cap

10.7B

Sector

Health Care

ML Signal

SELL

Logo SM Energy Company

SM

SM Energy Company

SELL

Current Price

$39.37

Market Cap

9.1B

Sector

Energy

ML Signal

SELL

Company Overview

Basic Information
Metric
CYTK
SM
Founded
1997
1908
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
9.1B
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
CYTK
SM
Price
$62.30
$39.37
Analyst Decision
Strong Buy
Buy
Analyst Count
23
18
Target Price
★ $109.40
$44.56
AVG Volume (30 Days)
2.0M
★ 3.1M
Earning Date
11-04-2026
11-03-2026
Dividend Yield
N/A
★ 2.35%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 3.34
Revenue
$13,368,000.00
★ $3,154,000,000.00
Revenue This Year
$72.63
$157.39
Revenue Next Year
$181.06
$0.50
P/E Ratio
★ N/A
$11.24
Revenue Growth
N/A
★ 17.24
52 Week Low
$54.30
$17.45
52 Week High
$88.31
$41.56

Technical Indicators

Market Signals
Indicator
CYTK
SM
Relative Strength Index (RSI) 36.80 64.35
Support Level $59.21 $27.39
Resistance Level $67.65 $41.56
Average True Range (ATR) 2.01 1.10
MACD 0.31 0.40
Stochastic Oscillator 34.67 98.69

Price Performance

Historical Comparison
CYTK
SM

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About SM SM Energy Company

SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and NGLs in Texas and Utah. The Company operates in the oil and gas extraction industry, focused on exploration and production activities, onshore in the United States. Its portfolio is comprised of assets in the Midland Basin of West Texas, the Maverick Basin of South Texas, and the Uinta Basin of northeastern Utah.

Share on Social Networks: